Should β Blockers Remain First Choice in the Treatment of Primary Hypertension? A Meta-AnalysisLindholm LH, Carlberg B, Samuelsson O (Umeá Univ, Sweden; Univ Hosp, Göteborg, Sweden) Lancet 366:1545-1553, 2005§